Cui Guanggen, Kobashigawa Jon, Margarian Armen, Sen Luyi
Department of Medicine, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1679, USA.
Transplantation. 2003 Jul 15;76(1):137-42. doi: 10.1097/01.TP.0000071933.14397.43.
The precise incidence and cause of atrioventricular block (AVB) after heart transplantation remain uncertain.
After surgery, immediate and follow-up electrocardiograms from 1047 consecutive patients who underwent heart transplantation were reviewed for AVB and correlated with clinical symptoms, laboratory data, rejection grade, and echocardiogram and coronary angiography findings. A total of 113 patients demonstrated various kinds of AVB; the incidence was 10.8%. First-degree AVB occurred in 87 patients, 37 of whom also demonstrated persistent atrial tachyarrhythmias (ATAs). In 30 patients, first-degree AVB occurred 7 days to 120 months after heart transplantation. Among those, 88% demonstrated cellular rejection, and 20% developed transplant coronary artery disease (TCAD). Fifty patients demonstrated first-degree AVB without ATA, 32 of whom developed AVB from operative day 7 to 156 months. The incidence of cellular rejection was significantly lower (36%, P<0.01), and the rejection was less severe. In 18 patients, AVB occurred early postoperatively (0-7 days), and most were secondary to surgical injury. Second-degree AVB Mobitz I occurred in six patients (four patients with TCAD and two patients undergoing percutaneous transluminal coronary angioplasty). One patient developed Mobitz II during coronary artery stenting. Complete AVB (CAVB) occurred in 19 patients. Nine episodes of CAVB occurred during endomyocardial biopsy or coronary angiography, and four occurred immediately after heart transplantation as the result of surgical insult.
These results indicate that first-degree AVB is causatively related to cellular rejection and TCAD-induced atrial conduction disturbance. Second-degree AVB and CAVB were mainly the consequences of surgical and catheter intervention injury.
心脏移植后房室传导阻滞(AVB)的确切发病率及病因仍不明确。
术后,对1047例连续接受心脏移植患者的即刻及随访心电图进行回顾,以评估AVB情况,并与临床症状、实验室数据、排斥反应分级、超声心动图及冠状动脉造影结果进行关联分析。共有113例患者出现各种类型的AVB,发病率为10.8%。87例患者发生一度AVB,其中37例还伴有持续性房性快速心律失常(ATA)。30例患者在心脏移植后7天至120个月发生一度AVB。其中,88%出现细胞性排斥反应,20%发生移植冠状动脉疾病(TCAD)。50例患者出现无ATA的一度AVB,其中32例在术后第7天至156个月发生AVB。细胞性排斥反应的发生率显著较低(36%,P<0.01),且排斥反应较轻。18例患者在术后早期(0 - 7天)发生AVB,多数继发于手术损伤。6例患者发生二度莫氏I型AVB(4例合并TCAD,2例接受经皮冠状动脉腔内血管成形术)。1例患者在冠状动脉支架置入过程中发生莫氏II型AVB。19例患者发生完全性AVB(CAVB)。9次CAVB发作发生于心内膜心肌活检或冠状动脉造影期间,4次在心脏移植后即刻因手术损伤所致。
这些结果表明,一度AVB与细胞性排斥反应及TCAD引起的心房传导障碍有关。二度AVB和CAVB主要是手术及导管介入损伤的结果。